In 2017, the Food and Drug Administration (FDA) approved Ozempic, which contains semaglutide as the main active ingredient, as a treatment for type 2 diabetes
Suitable candidates typically include adults with a Body Mass Index (BMI) of 30 kg/m or higher, indicating obesity, or those with a BMI of at least 27 kg/m and weight-related health conditions, such as elevated cholesterol levels, hypertension, or type 2 diabetes
Top 5 Brands That Win With GLP-1 Friendly Foods GLP-1 medications are reshaping how consumers approach food
This reduces oxidative stress and replenishes living cells
Introduction Alcohol use disorder (AUD) affects 29.5 million individuals greater than 12 years old and is one of the top causes of avoidable deaths, causing approximately 178,000 deaths annually ( The Alcohol Use Disorders Identification Test (AUDIT) is a screening tool developed by the World Health Organization (WHO) to help individuals recognize potential alcohol-related issues ( GLP-1 receptor agonists, developed initially as diabetes medications, have gained popularity due to their ability to suppress appetite and reduce the speed of gastric emptying, resulting in weight loss ( This case report serves to augment the existing body of evidence supporting the favorable impact of GLP-1 receptor agonists, not only on diabetes and weight management but also on AUD
Head-drop: a frequent feature in late onset myasthenia gravis
